LEXINGTON, Mass.--(BUSINESS WIRE)--Feb. 26, 2014--
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that it will
report its fourth quarter and year-end 2013 financial results on March
11, 2014, before market open.
Following the announcement, management will host a conference call and
webcast at 10:00 a.m. ET that morning to discuss the fourth quarter and
year-end 2013 financial results and provide clinical updates.
The conference call can be accessed by dialing (877) 407-8035 (U.S.) or
(201) 689-8035 (International). For those unable to join the live call,
a replay will be available from 2:00 p.m. ET on March 11 through 11:59
p.m. ET on March 18. To access the replay, please dial (877) 660-6853
(U.S.) or (201) 612-7415 (International) and refer to conference ID
The live webcast
can be accessed by visiting the Investor
Relations section of the Synta Pharmaceuticals website, www.syntapharma.com.
The webcast will also be archived under Webcasts
and Events within the Investor Relations section of the Company's
About Synta Pharmaceuticals
Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on
discovering, developing, and commercializing small molecule drugs to
extend and enhance the lives of patients with severe medical conditions,
including cancer and chronic inflammatory diseases. Synta has a unique
chemical compound library, an integrated discovery engine, and a diverse
pipeline of clinical- and preclinical-stage drug candidates with
distinct mechanisms of action and novel chemical structures. All Synta
drug candidates were invented by Synta scientists using our compound
library and discovery capabilities. For more information, please visit www.syntapharma.com.
Source: Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp.
Senior Vice President, Corporate Development
Andrea Rabney, 212-600-1494
Eliza Schleifstein, 917-763-8106